First Header Logo Second Header Logo

James Hoekstra

Concepts (260)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Acute Coronary Syndrome
34
2017
196
3.600
Why?
Myocardial Infarction
29
2018
475
2.650
Why?
Emergency Service, Hospital
38
2018
474
2.260
Why?
Platelet Aggregation Inhibitors
14
2015
83
1.860
Why?
Chest Pain
20
2018
208
1.740
Why?
Anticoagulants
13
2015
122
1.260
Why?
Body Surface Potential Mapping
4
2012
12
1.090
Why?
Electrocardiography
26
2016
605
1.070
Why?
Risk Assessment
23
2016
1429
0.960
Why?
Emergency Medicine
6
2010
120
0.870
Why?
Myocardial Ischemia
8
2012
107
0.850
Why?
Critical Pathways
5
2018
49
0.800
Why?
Platelet Glycoprotein GPIIb-IIIa Complex
13
2013
30
0.760
Why?
Hospitalists
3
2008
9
0.690
Why?
Emergency Treatment
5
2010
42
0.670
Why?
Registries
15
2016
298
0.660
Why?
Practice Guidelines as Topic
13
2011
408
0.560
Why?
Humans
76
2018
32114
0.560
Why?
Angina, Unstable
6
2007
21
0.540
Why?
Middle Aged
52
2018
11839
0.540
Why?
Aged
45
2018
10314
0.510
Why?
Male
57
2018
19217
0.500
Why?
Decision Support Techniques
4
2017
128
0.490
Why?
Female
55
2018
20015
0.470
Why?
Myocardial Revascularization
6
2016
41
0.460
Why?
Health Services Accessibility
3
2010
242
0.460
Why?
Thrombosis
3
2009
73
0.450
Why?
Troponin
10
2016
106
0.440
Why?
Angina Pectoris
3
2013
22
0.430
Why?
Coronary Disease
7
2007
211
0.420
Why?
Professional Competence
1
2012
19
0.420
Why?
Peptide Fragments
8
2015
399
0.410
Why?
Pattern Recognition, Automated
1
2012
36
0.410
Why?
Diagnosis, Computer-Assisted
1
2012
53
0.400
Why?
Academic Medical Centers
2
2010
158
0.390
Why?
United States
23
2016
3976
0.390
Why?
Guideline Adherence
8
2011
120
0.390
Why?
Cardiology
4
2016
99
0.380
Why?
Coronary Thrombosis
2
2008
14
0.370
Why?
Algorithms
4
2012
495
0.370
Why?
Severity of Illness Index
6
2016
881
0.370
Why?
Transportation of Patients
1
2010
26
0.360
Why?
Delivery of Health Care, Integrated
1
2010
32
0.360
Why?
Exercise Test
5
2016
227
0.360
Why?
Enoxaparin
7
2015
20
0.350
Why?
Coronary Artery Bypass
8
2015
103
0.350
Why?
Coronary Artery Disease
3
2008
401
0.350
Why?
Time Factors
16
2016
2151
0.340
Why?
Cardiology Service, Hospital
3
2015
23
0.340
Why?
Education, Medical, Continuing
5
2014
55
0.340
Why?
Hirudins
8
2015
19
0.340
Why?
Clinical Protocols
4
2016
97
0.330
Why?
Heparin
7
2013
73
0.330
Why?
Sensitivity and Specificity
8
2017
582
0.330
Why?
Heart Diseases
2
2011
116
0.320
Why?
Adrenergic beta-Antagonists
4
2009
61
0.310
Why?
Creatine Kinase, MB Form
7
2007
9
0.310
Why?
Antithrombins
3
2015
3
0.310
Why?
Fibrinolytic Agents
5
2009
70
0.310
Why?
Peripheral Vascular Diseases
1
2008
35
0.300
Why?
Continuity of Patient Care
1
2008
69
0.290
Why?
Adult
21
2018
9380
0.290
Why?
Aspirin
6
2010
63
0.290
Why?
Treatment Outcome
15
2015
3306
0.290
Why?
Predictive Value of Tests
10
2017
876
0.280
Why?
Hemorrhage
6
2015
100
0.270
Why?
Syncope
1
2006
26
0.260
Why?
Clinical Competence
2
2009
333
0.250
Why?
Patient Selection
2
2011
276
0.240
Why?
Credentialing
1
2004
9
0.240
Why?
Politics
1
2004
22
0.230
Why?
Patient Discharge
4
2015
188
0.230
Why?
Pacemaker, Artificial
1
2004
19
0.230
Why?
Postural Balance
1
2016
182
0.230
Why?
Recombinant Proteins
8
2015
247
0.230
Why?
North Carolina
8
2016
1538
0.230
Why?
Ticlopidine
5
2009
17
0.220
Why?
Hospital Mortality
7
2009
198
0.220
Why?
Pesticides
1
2016
199
0.220
Why?
Reproducibility of Results
5
2016
765
0.220
Why?
Clinical Trials as Topic
4
2008
301
0.220
Why?
Occupational Exposure
1
2016
232
0.220
Why?
Survival Analysis
6
2013
483
0.210
Why?
Emigrants and Immigrants
1
2016
244
0.210
Why?
Transients and Migrants
1
2016
297
0.210
Why?
Magnetic Resonance Imaging
4
2013
1328
0.210
Why?
Aged, 80 and over
13
2016
3990
0.210
Why?
Delivery of Health Care
3
2014
161
0.200
Why?
Heart Conduction System
3
2008
72
0.200
Why?
Risk Factors
12
2017
3880
0.200
Why?
Peptides
4
2013
120
0.200
Why?
Troponin T
4
2007
81
0.200
Why?
Atherosclerosis
1
2008
766
0.200
Why?
Patient Care Team
2
2014
129
0.190
Why?
Cohort Studies
6
2017
1817
0.190
Why?
Logistic Models
10
2010
783
0.180
Why?
Evidence-Based Medicine
5
2011
218
0.180
Why?
Prospective Studies
7
2016
2283
0.180
Why?
Patient Admission
2
2011
60
0.180
Why?
Acute Disease
8
2011
253
0.170
Why?
Hispanic Americans
1
2016
940
0.170
Why?
Creatine Kinase
3
2003
11
0.170
Why?
Coronary Angiography
4
2018
153
0.170
Why?
Isoenzymes
3
2003
61
0.170
Why?
Quality of Health Care
3
2010
147
0.160
Why?
Odds Ratio
7
2011
472
0.150
Why?
Early Diagnosis
2
2008
62
0.150
Why?
Diagnostic Errors
2
2009
43
0.140
Why?
Troponin C
1
2017
9
0.140
Why?
Drug Therapy, Combination
4
2015
288
0.140
Why?
Observation
2
2013
25
0.140
Why?
Triage
3
2009
72
0.140
Why?
Pyridines
2
2013
76
0.130
Why?
Diagnostic Imaging
1
2016
94
0.130
Why?
Death
1
2015
49
0.130
Why?
Health Care Costs
1
2016
118
0.130
Why?
Prognosis
7
2016
1497
0.130
Why?
Cause of Death
3
2016
236
0.130
Why?
Hospitalization
3
2010
470
0.120
Why?
Age Factors
5
2016
1189
0.120
Why?
Documentation
2
2004
46
0.120
Why?
Retrospective Studies
9
2016
3510
0.120
Why?
Follow-Up Studies
7
2016
2265
0.120
Why?
Decision Making
1
2016
195
0.120
Why?
Randomized Controlled Trials as Topic
3
2016
510
0.120
Why?
Double-Blind Method
3
2013
525
0.120
Why?
Cyclic N-Oxides
1
2013
8
0.110
Why?
Heart Failure
4
2007
639
0.110
Why?
Vasodilator Agents
1
2013
62
0.110
Why?
Troponin I
3
2007
22
0.100
Why?
Diagnosis, Differential
3
2016
517
0.100
Why?
Observer Variation
1
2012
105
0.100
Why?
Syndrome
4
2007
72
0.100
Why?
Combined Modality Therapy
3
2008
560
0.100
Why?
Health Personnel
2
2011
121
0.100
Why?
Quality Assurance, Health Care
2
2010
72
0.100
Why?
Single-Blind Method
1
2012
203
0.100
Why?
Singapore
5
2016
10
0.100
Why?
Cardiovascular Agents
2
2009
23
0.100
Why?
Hospital Costs
1
2011
38
0.100
Why?
Health Expenditures
1
2011
66
0.090
Why?
Length of Stay
4
2015
314
0.090
Why?
Patient Care
1
2011
30
0.090
Why?
Regional Health Planning
1
2010
8
0.090
Why?
Thrombolytic Therapy
2
2008
63
0.090
Why?
Inpatients
1
2011
85
0.090
Why?
Critical Care
1
2011
106
0.090
Why?
Women
1
2010
12
0.090
Why?
Organizational Innovation
1
2010
31
0.090
Why?
Health Knowledge, Attitudes, Practice
1
2014
357
0.090
Why?
Program Development
1
2010
97
0.090
Why?
Program Evaluation
1
2010
186
0.090
Why?
Minority Groups
1
2010
83
0.090
Why?
Case-Control Studies
3
2016
898
0.090
Why?
Polysaccharides
1
2009
13
0.080
Why?
Point-of-Care Systems
1
2009
44
0.080
Why?
Internet
2
2007
198
0.080
Why?
Postoperative Hemorrhage
1
2008
42
0.080
Why?
Emergency Medical Services
2
2010
178
0.080
Why?
Attitude of Health Personnel
2
2009
184
0.080
Why?
Myocardial Reperfusion
1
2007
10
0.080
Why?
Cardiovascular Diseases
1
2016
1128
0.080
Why?
Drug Utilization Review
1
2007
17
0.070
Why?
Vascular Surgical Procedures
1
2008
88
0.070
Why?
Incidence
3
2016
1199
0.070
Why?
Healthcare Disparities
1
2009
169
0.070
Why?
Multicenter Studies as Topic
4
2007
105
0.070
Why?
Recurrence
1
2007
263
0.070
Why?
Sex Factors
2
2005
667
0.070
Why?
Insurance, Health
2
2004
95
0.070
Why?
Confidence Intervals
3
2011
149
0.060
Why?
Ventricular Function, Left
1
2007
245
0.060
Why?
Asian Continental Ancestry Group
1
2005
108
0.060
Why?
Professional Autonomy
1
2004
6
0.060
Why?
Reimbursement Mechanisms
1
2004
13
0.060
Why?
Specialty Boards
1
2004
9
0.060
Why?
Personnel Staffing and Scheduling
1
2004
19
0.060
Why?
Cost Savings
2
2016
34
0.060
Why?
Malpractice
1
2004
21
0.060
Why?
Medical Staff, Hospital
1
2004
20
0.060
Why?
Medically Uninsured
1
2004
32
0.060
Why?
Patient Transfer
1
2004
43
0.060
Why?
Survival Rate
2
2016
877
0.060
Why?
Costs and Cost Analysis
2
2016
100
0.060
Why?
Insurance Coverage
1
2004
75
0.060
Why?
Total Quality Management
1
2002
17
0.050
Why?
Aging
1
2009
946
0.050
Why?
ROC Curve
2
2016
164
0.050
Why?
Comorbidity
3
2009
566
0.050
Why?
American Medical Association
2
2011
5
0.050
Why?
Chi-Square Distribution
2
2009
297
0.040
Why?
Health Care Surveys
2
2009
185
0.040
Why?
Forecasting
2
2010
143
0.040
Why?
Immunoglobulin Fab Fragments
2
2008
15
0.040
Why?
Tyrosine
2
2008
23
0.040
Why?
Medical History Taking
1
2016
37
0.030
Why?
Antibodies, Monoclonal
2
2008
246
0.030
Why?
Referral and Consultation
1
2016
142
0.030
Why?
Echocardiography, Stress
1
2015
27
0.030
Why?
Sex Distribution
2
2006
191
0.030
Why?
Age Distribution
2
2006
206
0.030
Why?
Research Design
2
2007
315
0.030
Why?
Evaluation Studies as Topic
2
2004
44
0.030
Why?
Multivariate Analysis
2
2007
684
0.030
Why?
Consensus
2
2004
85
0.030
Why?
Stents
2
2008
177
0.030
Why?
Databases, Factual
1
2016
355
0.030
Why?
Health Resources
1
2014
33
0.030
Why?
Injections, Intravenous
1
2013
78
0.030
Why?
Infusions, Intravenous
1
2013
100
0.030
Why?
Efficiency, Organizational
1
2013
18
0.030
Why?
Risk
1
2013
321
0.030
Why?
Arrhythmias, Cardiac
2
2003
89
0.030
Why?
Peer Review, Health Care
1
2011
4
0.030
Why?
Telecommunications
1
2011
7
0.030
Why?
Radionuclide Imaging
1
2011
26
0.030
Why?
Patient Readmission
1
2013
126
0.030
Why?
Staff Development
1
2011
16
0.020
Why?
Coronary Care Units
1
2011
4
0.020
Why?
Models, Economic
1
2011
20
0.020
Why?
Drug Costs
1
2011
47
0.020
Why?
Adenosine
1
2011
59
0.020
Why?
Proportional Hazards Models
1
2013
753
0.020
Why?
Dobutamine
1
2011
69
0.020
Why?
Echocardiography
1
2011
159
0.020
Why?
Heparin, Low-Molecular-Weight
1
2010
6
0.020
Why?
State Health Plans
1
2010
5
0.020
Why?
Myocardium
1
2011
186
0.020
Why?
Heart
1
2011
177
0.020
Why?
Linear Models
1
2011
449
0.020
Why?
Bradycardia
1
2009
16
0.020
Why?
Drug Utilization
1
2009
49
0.020
Why?
Hypotension
1
2009
47
0.020
Why?
Benchmarking
1
2009
23
0.020
Why?
Societies, Medical
1
2010
164
0.020
Why?
Drug Administration Schedule
1
2009
276
0.020
Why?
Thiophenes
1
2008
23
0.020
Why?
Atherectomy
1
2008
4
0.020
Why?
Piperazines
1
2008
54
0.020
Why?
Coronary Stenosis
1
2007
30
0.020
Why?
Preoperative Care
1
2008
114
0.020
Why?
Statistics, Nonparametric
1
2007
130
0.020
Why?
Quality Indicators, Health Care
1
2007
59
0.020
Why?
Diagnosis-Related Groups
1
2006
11
0.020
Why?
Systole
1
2007
99
0.020
Why?
Cross-Sectional Studies
1
2011
1542
0.020
Why?
Tomography, X-Ray Computed
1
2011
919
0.020
Why?
Medical Records
1
2006
76
0.020
Why?
Cooperative Behavior
1
2006
81
0.020
Why?
Data Collection
1
2006
182
0.020
Why?
Ventricular Dysfunction, Left
1
2007
170
0.020
Why?
Physicians
1
2006
159
0.010
Why?
Stroke Volume
1
2007
348
0.010
Why?
Cross-Over Studies
1
2003
95
0.010
Why?
Catheter Ablation
1
2004
67
0.010
Why?
Creatinine
1
2003
195
0.010
Why?
Continental Population Groups
1
2004
237
0.010
Why?
Prevalence
1
2005
989
0.010
Why?
Pilot Projects
1
2003
548
0.010
Why?
African Americans
1
2003
1425
0.010
Why?
Hoekstra's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (260)
Explore
_
Co-Authors (14)
Explore
_
Similar People (49)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_